Stocks in play: Medicenna Therapeutics Corp
Announced that its management team will participate in two upcoming investor conferences in February. The company will also host one-on-one meetings with investors during these events. Medicenna Therapeutics Corp shares T.MDNA are trading unchanged at $1.26.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.